SciELO - Scientific Electronic Library Online

 
vol.24 número2Pneumonias Pneumocócicas e Pneumonias por influenza A: Estudo ComparativoMielinólise Centropôntica e Extrapôntica: Experiência de um Centro de Transplante Hepático índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Medicina Interna

versión impresa ISSN 0872-671X

Resumen

SANTOS, Luís Ramos dos et al. Predictors of Inappropriate Proton Pump Inhibitor Prescription in an Internal Medicine Department. Medicina Interna [online]. 2017, vol.24, n.2, pp.112-118. ISSN 0872-671X.

Introduction:Proton pump inhibitors (PPIs) are used in the treatment of gastrointestinal pathology and prevention of upper gastrointestinal bleeding. They are frequently misused in hospitalized patients. Methods:We conducted an observational cross-sectional study between 15th March and 15th May 2015 to evaluate the prescription pattern of PPIs in an Internal Medicine ward regarding indications and costs. Results:Five hundred and eighty five admissions were included with an average age of 75 years. One hundred and sixty three cases were medicated with a PPI prior to admission, half of them without indication. Three hundred seventy-two cases were prescribed a PPI on admission/during hospital stay but only 63 cases had a proper indication meaning that 83% were inadequately medicated. Predictors of inadequate PPI prescription were female sex, age = 75 years and being medicated with a PPI prior to admission. Conclusion: Total costs, directly related to PPIs were set at €1079.96, on average €2.72 per episode. Therapy with PPIs should be reviewed to decrease inadequate prescriptions and costs.

Palabras clave : Hospital Departments; Inappropriate Prescribing; Internal Medicine; Proton Pump Inhibitors/therapeutic uso.

        · resumen en Portugués     · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons